Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carl Brooks

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Radiologic Technology|September 14, 2013
Shared experience: stress managementCarl Brooks
Radiologic Technology|September 8, 2016
Research ExcellenceCarl Brooks
Radiologic Technology|September 18, 2015
Imaging C7 Through T1 Carl Brooks
Radiologic Technology|March 17, 2017
Modification of the Robert MethodCarl Brooks
Bioorganic & Medicinal Chemistry Letters|July 15, 2010
Identification of a sulfonamide series of CCR2 antagonistsSimon Peace, Joanne Philp, Carl Brooks, et al.
Bioorganic & Medicinal Chemistry Letters|October 20, 2012
In vivo activity of an azole series of CCR2 antagonistsChris A Smethurst, Nicola Bevan, Carl Brooks, et al.
Bioorganic & Medicinal Chemistry Letters|April 26, 2011
Structure-activity relationship studies of novel 3-oxazolidinedione-6-naphthyl-2-pyridinones as potent and orally bioavailable EP3 receptor antagonistsÁngel I Morales-Ramos, Yue H Li, Mark Hilfiker, et al.
Journal of Medicinal Chemistry|October 19, 2018
Discovery of Pyrrolidine Sulfonamides as Selective and Orally Bioavailable Antagonists of Transient Receptor Potential Vanilloid-4 (TRPV4)Edward J Brnardic, Guosen Ye, Carl Brooks, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Novel 3-Oxazolidinedione-6-aryl-pyridinones as Potent, Selective, and Orally Active EP3 Receptor AntagonistsJian Jin, Angel Morales-Ramos, Patrick Eidam, et al.
Journal of Medicinal Chemistry|December 1, 2018
Design and Optimization of Sulfone Pyrrolidine Sulfonamide Antagonists of Transient Receptor Potential Vanilloid-4 with in Vivo Activity in a Pulmonary Edema ModelJoseph E Pero, Jay M Matthews, David J Behm, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Radiologic Technology|September 14, 2013
Shared experience: stress managementCarl Brooks
Radiologic Technology|September 8, 2016
Research ExcellenceCarl Brooks
Radiologic Technology|September 18, 2015
Imaging C7 Through T1 Carl Brooks
Radiologic Technology|March 17, 2017
Modification of the Robert MethodCarl Brooks
Bioorganic & Medicinal Chemistry Letters|July 15, 2010
Identification of a sulfonamide series of CCR2 antagonistsSimon Peace, Joanne Philp, Carl Brooks, et al.
Bioorganic & Medicinal Chemistry Letters|October 20, 2012
In vivo activity of an azole series of CCR2 antagonistsChris A Smethurst, Nicola Bevan, Carl Brooks, et al.
Bioorganic & Medicinal Chemistry Letters|April 26, 2011
Structure-activity relationship studies of novel 3-oxazolidinedione-6-naphthyl-2-pyridinones as potent and orally bioavailable EP3 receptor antagonistsÁngel I Morales-Ramos, Yue H Li, Mark Hilfiker, et al.
Journal of Medicinal Chemistry|October 19, 2018
Discovery of Pyrrolidine Sulfonamides as Selective and Orally Bioavailable Antagonists of Transient Receptor Potential Vanilloid-4 (TRPV4)Edward J Brnardic, Guosen Ye, Carl Brooks, et al.
ACS Medicinal Chemistry Letters|June 6, 2014
Novel 3-Oxazolidinedione-6-aryl-pyridinones as Potent, Selective, and Orally Active EP3 Receptor AntagonistsJian Jin, Angel Morales-Ramos, Patrick Eidam, et al.
Journal of Medicinal Chemistry|December 1, 2018
Design and Optimization of Sulfone Pyrrolidine Sulfonamide Antagonists of Transient Receptor Potential Vanilloid-4 with in Vivo Activity in a Pulmonary Edema ModelJoseph E Pero, Jay M Matthews, David J Behm, et al.
Pageof 1